1: (ROOT (S (S (NP (NN Study)) (VP (VBZ Finds) (SBAR (S (RBS Most) (VP (VB Develop) (NP (NP (NNS Antibodies)) (PP (PP (IN To) (NP (NNP COVI-19Chongqing) (NNP Medical) (NNP University))) (SBAR (S (NP (NNP China)) (VP (VBZ has) (VP (VBN found) (SBAR (IN that) (S (NP (NP (RB nearly) (NN everyone)) (SBAR (WHNP (WP who)) (S (VP (VBZ recovers) (PP (IN from) (NP (CD COVI-19))))))) (VP (MD will) (VP (VB develop) (NP (NP (NNS antibodies)) (PP (IN to) (NP (PRP it))))))))))))))))))) (: ;) (S (NP (NP (CD 95) (NN %)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB have) (VP (VBN had) (NP (DT the) (JJ immune) (NNS cells)) (PP (IN within) (NP (CD three) (NNS weeks)))))))))) (. .)))
2: (ROOT (S (S (PP (VBG According) (PP (IN to) (NP (DT the) (JJ recent) (NN research)))) (NP (NP (RB nearly) (NN everyone)) (SBAR (WHNP (WP who)) (S (VP (VP (VBZ becomes) (ADJP (VBN infected) (PP (IN with) (NP (DT this) (NN virus))))) (CC and) (VP (VBZ goes) (PRT (RP on)) (S (VP (TO to) (VP (VB recover))))))))) (VP (MD will) (VP (VB develop) (NP (NP (NNS antibodies)) (PP (IN to) (NP (PRP it))))))) (: ;) (S (NP (NP (CD 95) (NN %)) (PP (IN of) (NP (DT the) (CD 285) (NNS patients)))) (VP (VBD developed) (NP (NP (NP (DT both) (NNS types)) (PP (IN of) (NP (JJ immune) (NNS cells)))) (SBAR (WHNP (WDT that)) (S (VP (VBP fight) (NP (DT this) (NN virus)))))))) (. .)))
3: (ROOT (S (ADVP (RB Globally)) (NP (NN antibody) (NN testing)) (VP (VBZ is) (VP (VBG being) (VP (VBN geared) (PRT (RP up)) (PP (IN in) (NP (DT an) (NN attempt) (S (VP (TO to) (VP (VB see) (SBAR (WHNP (WP who)) (S (VP (VP (VBZ has) (ADVP (RB already)) (VP (VBN had) (NP (DT the) (NN virus)))) (CC and) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB develop) (NP (NP (DT some) (JJ potential) (NN form)) (PP (IN of) (NP (NP (JJ natural) (NN protection)) (PP (IN against) (NP (NN reinfection))) (PP (IN from) (NP (HYPH COVI-19)))))))))))))))))))))) (. .)))
4: (ROOT (S (ADVP (RB However)) (, ,) (NP (JJ many) (NNS questions)) (VP (VBP remain) (PP (IN around) (NP (DT these) (NNS antibodies))) (PP (JJ such) (IN as) (SBAR (SBAR (IN whether) (S (NP (NN everyone)) (VP (MD will) (VP (VB develop) (NP (PRP them)))))) (, ,) (SBAR (WHNP (WDT what) (NN level)) (S (VP (VBZ is) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB confer) (NP (NN protection))))))))) (, ,) (CC and) (SBAR (WHNP (RB just) (WRB how) (JJ long)) (S (NP (NP (DT the) (NN protection)) (SBAR (IN if) (NP (DT any)))) (VP (MD will) (VP (VB last)))))))) (. .)))
5: (ROOT (SINV (S (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB help) (S (VP (VB answer) (NP (NP (CD one)) (PP (IN of) (NP (DT those) (NN question)))))))))))) (CC and) (S (NP (PRP it)) (`` `) (VP (VBZ brings) (NP (ADJP (RB muc) (HYPH -) (VBN needed)) (NN clarity)) (, ,) (ADVP (IN along) (PP (IN with) (NP (JJ renewed) (NN enthusiasm)))) (, ,) (PP (IN to) (NP (NNS efforts) (S (VP (TO to) (VP (VB develop) (CC and) (VB implement) (NP (NP (JJ widescale) (NN antibody) (NN testing)) (PP (IN for) (NP (NNP SAR) (HYPH -) (HYPH Co-2)))))))))))) (, ,) ('' ') (VP (VBD wrote)) (NP (NNP Dr) (NNP Francis) (NNP Collins)) (PP (IN on) (NP (NP (NP (NP (DT the) (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health))) (POS 's)) (NNP Director) (POS 's)) (NN blog))) (. .)))
6: (ROOT (S (S (PP (IN By) (NP (DT this) (NN point))) (NP (RB just) (RB about) (NN everyone)) (VP (VP (VBZ has) (VP (VBN heard) (PP (IN about) (NP (NNS antibodies))))) (CC and) (VP (VBZ knows) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP are) (NP (NP (JJ immune) (NNS cells)) (SBAR (WHNP (WDT that)) (S (NP (DT the) (NN body)) (VP (VBZ develops) (PP (IN in) (NP (NP (DT a) (JJ unique) (NN response)) (PP (IN to) (NP (DT a) (VBN given) (NN pathogen))))))))))))))) (, ,) (CC and) (S (SBAR (IN if) (S (NP (PRP you)) (VP (VBP have) (ADVP (RB never)) (VP (VBN had) (NP (NP (NN exposure)) (PP (IN to) (NP (DT a) (NN virus) (CC or) (NN bacterium)))))))) (NP (PRP you)) (VP (MD will) (RB not) (VP (VB develop) (NP (NP (NNS antibodies)) (PP (IN to) (NP (PRP it))))))) (. .)))
7: (ROOT (S (S (PP (IN In) (NP (NP (NN response)) (PP (IN to) (NP (JJS most) (NNS infections))))) (NP (DT the) (NN body)) (VP (MD will) (VP (VB start) (S (VP (VBG producing) (NP (NP (DT these) (JJ specialized) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (MD will) (VP (VB recognize) (CC and) (VB target) (NP (DT an) (NN infection)) (SBAR (SINV (MD should) (NP (PRP it)) (VP (VB occur) (ADVP (RB again))))))))))))))) (, ,) (S (ADVP (RB often)) (NP (PRP it)) (VP (MD will) (VP (VB neutralize) (NP (DT the) (NN pathogen)) (ADVP (RB entirely))))) (. .)))
8: (ROOT (S (NP (NNS Coronaviruses)) (VP (VBP are) (PP (PP (ADVP (RB much)) (IN like) (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (VBP cause) (NP (DT the) (JJ common) (NN cold))))))) (, ,) (PP (IN from) (SBAR (SBAR (WHNP (WP what)) (S (VP (VBZ is) (VP (VBN known) (PP (IN about) (NP (JJ other) (NNS coronaviruses))))))) (NP (NNS scientists)) (VP (VBP are) (VP (VBG guessing) (SBAR (IN that) (S (NP (NNS humans)) (VP (MD will) (VP (VB develop) (NP (NNS antibodies)) (PP (IN against) (NP (DT this) (JJ novel) (NN version))))))))))))) (. .)))
9: (ROOT (S (PP (IN Up) (PP (IN until) (ADVP (RB recently)))) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (VBG knowing)) (PP (IN for) (ADJP (JJ sure)))) (SBAR (IN until) (S (NP (PRP they)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB study) (NP (NNS patients)))))))))) (. .)))
10: (ROOT (S (S (PP (IN In) (NP (DT this) (NN study))) (NP (NP (DT the) (NN blood)) (PP (IN of) (NP (CD 258) (NNS patients)))) (VP (VBD was) (VP (VBN monitored) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (JJ immune) (NNS cells)))))))) (: ;) (NP (NNS humans)) (VBP produce) (NP (CD two) (NNS types)) (PP (IN of) (NP (NNS antibodies))) (NNP Igm) (CC and) (. IgG.)))
11: (ROOT (S (S (S (NP (DT The) (JJ first)) (VP (VBZ is) (VP (VBN produced) (PP (ADVP (RB early)) (IN after) (NP (NN infection)))))) (CC and) (S (NP (DT these) (NNP IgM) (NNS antibodies)) (VP (VBP provide) (NP (NP (DT a) (JJ short) (NN burst)) (PP (IN of) (NP (NN protection)))) (PP (IN before) (S (VP (VBG fading) (ADVP (RB away)))))))) (: ;) (S (S (NP (NP (CD 40) (NN %)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD had) (VP (VBN produced) (NP (NNP IgM) (NNS antibodies)) (PP (IN within) (NP (NP (DT the) (JJ first) (NN week)) (PP (IN of) (NP (NN infection)))))))) (, ,) (CC and) (S (PP (IN after) (NP (NP (CD two) (NNS weeks)) (PP (IN of) (NP (NN observation))))) (NP (CD 95) (NN %)) (VP (VP (VBD had) (VP (VBN developed) (NP (NP (JJ detectable) (NNS levels)) (PP (IN of) (NP (NNP IgM)))))) (CC and) (VP (VBD were) (VP (VBG producing) (NP (NP (NNP IgG) (NNS antibodies)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP take) (NP (JJR longer)) (S (VP (TO to) (VP (VB develop))))) (CC but) (VP (VBP have) (NP (NP (JJR more) (NN potential)) (PP (IN for) (NP (NML (JJ long) (NN term)) (NN protection)))))))))))))) (. .)))
12: (ROOT (S (S (PP (IN In) (NP (DT a) (ADJP (VB follow) (RP up)) (NN study))) (NP (NN blood)) (VP (VBD was) (VP (VBN collected) (PP (IN from) (NP (DT another) (CD 69) (NNS patients)))))) (, ,) (CC and) (S (S (PP (IN within) (NP (CD 20) (NNS days))) (NP (QP (DT all) (CC but) (CD two)) (NNS patients)) (VP (VBD produced) (NP (NNS antibodies)))) (: ;) (S (NP (DT those) (CD two) (NNS patients)) (VP (VBD were) (NP (DT a) (JJ related) (NN mother) (CC and) (NN daughter))))) (. .)))
13: (ROOT (S (S (VP (TO To) (VP (VB determine) (SBAR (SBAR (WHNP (WHADJP (WRB how) (JJ much)) (NN protection)) (S (NP (DT these) (NNS antibodies)) (VP (VBP carry)))) (CC and) (PP (IN for) (SBAR (WHADVP (WRB how) (RB long)) (S (NP (PRP they)) (VP (VBP confer) (NP (NN immunity)))))))))) (NP (NNS scientists)) (VP (MD will) (VP (VB need) (S (VP (TO to) (VP (VB continue) (S (VP (TO to) (VP (VP (VB study) (NP (NNS patients))) (CC and) (VP (VB follow) (NP (PRP them)))))) (, ,) (S (ADVP (ADVP (RB perhaps)) (ADVP (RB even))) (VP (VBG doing) (NP (NN challenge) (NNS experiments)) (S (VP (TO to) (VP (VP (VB expose) (NP (PRP them)) (PP (IN to) (NP (DT the) (NN virus))) (ADVP (RB again))) (S (VP (TO to) (VP (VB see) (SBAR (IN if) (S (NP (PRP$ their) (NNS antibodies)) (VP (MD will) (VP (VB protect) (NP (PRP them)) (PP (IN from) (NP (NNS reinfections)))))))))))))))))))) (. .)))
14: (ROOT (S (ADVP (RB However)) (, ,) (SBAR (IN until) (S (NP (JJ enough) (NN time)) (VP (VBZ has) (VP (VBN passed) (SBAR (IN for) (S (NP (JJ such) (NNS studies)) (VP (TO to) (VP (VB be) (VP (VBN completed)))))))))) (NP (DT these) (NNS studies)) (VP (VBP are) (ADVP (RB indeed)) (NP (DT an) (JJ encouraging) (NN sign) (SBAR (IN that) (S (NP (DT the) (JJ human) (NN body)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB learn) (CC and) (VB develop) (NP (NP (NNS defenses)) (PP (IN against) (NP (CD COVI-19)))) (PP (IN after) (NP (NN exposure)))))))))))) (. .)))
15: (ROOT (S (SBAR (IN If) (S (NP (DT this)) (VP (VBZ turns) (PRT (RP out)) (S (VP (TO to) (VP (VB be) (NP (DT the) (NN case)))))))) (NP (NN humanity)) (VP (MD may) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB develop) (NP (NP (NP (DT some) (NN form)) (PP (IN of) (NP (NP (NN herd) (NN immunity)) (PP (IN against) (NP (CD COVI-19)))))) (SBAR (WHNP (WDT that)) (S (VP (MD would) (VP (VB help) (S (VP (TO to) (VP (VB keep) (NP (NP (JJ possible) (JJ future) (NNS cases)) (PP (IN of) (NP (DT this) (NN virus)))) (PP (IN from) (S (VP (S (VP (VBG reaching) (NP (NN epidemic) (NNS levels)))) (SBAR (IN as) (S (VP (VBP are) (ADVP (RB currently)) (VP (VBG being) (VP (VBN experienced) (PP (IN on) (NP (DT a) (JJ global) (NN scale))))))))))))))))))))))))) (. .)))
16: (ROOT (SINV (`` `) (S (NP (EX There)) (VP (VBZ 's) (ADVP (RB still)) (NP (NP (DT a) (NN way)) (SBAR (S (VP (TO to) (VP (VB go) (PP (IN with) (NP (NP (NML (DT both) (NN virus) (CC and) (NN antibody)) (NN testing)) (PP (IN for) (NP ($ COVI-19)))))))))))) (, ,) ('' ') (VP (VBD wrote)) (NP (NNP Dr) (NNP Collins)) (. .)))
17: (ROOT (S (CC But) (SBAR (IN as) (S (NP (NP (DT this) (NN study)) (CC and) (NP (NNS others))) (VP (VBP begin) (S (VP (TO to) (VP (VB piece) (ADVP (RB together)) (NP (NP (DT the) (JJ complex) (NN puzzle)) (PP (IN of) (NP (ADJP (JJ antibod) (HYPH -) (VBN mediated)) (NN immunity)))))))))) (, ,) (NP (NP (PRP it))) (VP (MD will) (VP (VB be) (ADJP (JJ possible)) (S (VP (TO to) (VP (VB learn) (NP (JJR more)) (PP (PP (IN about) (NP (NP (NP (DT the) (JJ human) (NN body) (POS 's)) (NN response)) (PP (IN to) (NP (NNP SAR) (HYPH -) (CD Co-2))))) (CC and) (ADVP (NN home) (RB in))) (PP (IN on) (NP (NP (PRP$ our) (NN goal)) (PP (IN of) (S (VP (VBG achieving) (NP (NP (ADJP (JJ safe) (, ,) (JJ effective) (, ,) (CC and) (JJ sustained)) (NN protection)) (PP (IN against) (NP (DT this) (JJ devastating) (NN disease)))))))))))))) (. .) ('' ')))
